The Expression of Fibroblast Activation Protein in Patients with Non-Small Cell Lung Cancer Patients

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523965-97-00

Enrollment

Registered

2025-12-16

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non small cell lung cancer

Brief summary

SUVmax, SUVmean and SUVpeak of the primary tumor, tumor recurrence, lymph node metastasis or distant metastasis

Detailed description

Histological confirmation of cancer in lesions with FAPI PET -imaging

Interventions

DRUG[18F]FAPI-74

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
SUVmax, SUVmean and SUVpeak of the primary tumor, tumor recurrence, lymph node metastasis or distant metastasis	—

Secondary

Measure	Time frame
Histological confirmation of cancer in lesions with FAPI PET -imaging	—

Countries

Finland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026